Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

Calviri, Inc., a biotech startup focused on ending deaths from cancer, announces that Skysong Innovations, the intellectual property management company for Arizona State University (“ASU”), granted Calviri an exclusive license to ASU’s Immunosignature patent portfolio. The portfolio consists of multiple granted and pending patents for the use and optimization of immunosignatures as an antibody-based diagnostic platform in the United States and the rest of the world.

The Immunosignature Technology was invented and originally developed by Stephen Albert Johnston, now CEO of Calviri, and his colleagues at ASU. The platform uses hundreds of thousands of chemically diverse peptides to provide an unbiased profile of an individual’s antibody repertoire. It has been applied to both infectious and chronic diseases in published reports. Initially intended as simply a diagnostic tool to detect disease onset, additional work has shown its potential for measuring disease severity and response to therapies.

“Adding the Immunosignature Platform to

Read More

Spectrum Health completes 200th diagnostic procedure for lung conditions using robotic technology

GRAND RAPIDS, MI — Spectrum Health physicians recently completed their 200th procedure using robotic technology to diagnose early-stage lung cancers, officials say.

The integrated health system’s use of a robotic bronchoscopy platform has resulted in the diagnosis of 20 percent more cases, according to an Oct. 12 news release. This improves patient outcomes by providing access to earlier treatment options with more accuracy.

Two years ago, Spectrum Health introduced Auris Health’s Monarch Platform, an innovative endoscopy tool. More recently, physicians have combined this with Phillips’ Cone Beam CT technology and augmented fluoroscopy to help diagnose with high precision.

“We are equipped with the two leading technologies in the market. By combining these two highly innovative technologies it will allow us to reach any area of concern with unprecedented accuracy,” said Dr. Gustavo Cumbo-Nacheli, director of bronchoscopy and interventional pulmonology for Spectrum Health.

“Soon we will have the ability not only

Read More

3D-printed nasal swabs work as well as commercial swabs for COVID-19 diagnostic testing, study finds — ScienceDaily

As COVID-19 quickly spread worldwide this spring, shortages of supplies, including the nasopharyngeal (nasal) swabs used to collect viral samples, limited diagnostic testing.

Now, a multisite clinical trial led by the University of South Florida Health (USF Health) Morsani College of Medicine and its primary hospital affiliate Tampa General Hospital (TGH) provides the first evidence that 3D-printed alternative nasal swabs work as well, and safely, as the standard synthetic flocked nasal swabs.

The results were published online Sept. 10 in Clinical Infectious Diseases. A commentary accompanying the paper cites the authors’ timely, collaborative response to supply chain disruptions affecting testing capacity early in the pandemic.

Seeking a solution to an unprecedented demand for nasal swabs at their own institution and others, USF Health researchers in the Departments of Radiology and Infectious Diseases reached out to colleagues at TGH; Northwell Health, New York’s largest health care provider; and leading 3D-printer

Read More

Global Ophthalmic Diagnostic & Monitoring Devices Market 2020: Emerging Technologies Driving Growth Opportunities

The “Global Ophthalmic Diagnostic & Monitoring Devices Market 2020: Emerging Technologies Driving Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.

This growth opportunity-technology (GO-TE) report covers the emerging technologies in ophthalmic diagnosis and monitoring and its various growth opportunities for the industry.

As the prevalence of eye diseases is estimated to rise in the coming years because of the growing aging population, lifestyle changes, and increasing incidence of chronic diseases, the demand for ophthalmic diagnosis and monitoring devices is also witnessing an upsurge. Adoption of technologies such as AI, IoT and telemedicine, as well as portable devices aids in the management of the estimated overwhelming need for eye screening by increasing the operational efficiency.

The report covers some of the recent innovations in various segments of ophthalmic diagnostic and monitoring devices. The report provides strategic recommendations to capitalize on this growing ophthalmic diagnostic and monitoring market. The research details

Read More